Literature DB >> 19074804

Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork.

Dorette Z Ellis1, William M Dismuke, Binna M Chokshi.   

Abstract

PURPOSE: Nitric oxide (NO) increases the rate at which aqueous humor exits the eye; however, the involvement of soluble guanylate cyclase (sGC) is unknown. This study investigated the role of sGC in mediating the NO-induced increases in outflow facility.
METHODS: Outflow facility was measured in porcine eyes using the anterior segment organ culture perfusion system. sGC activity was assessed by cGMP production in low-passage porcine and human trabecular meshwork (TM) cells and transformed human TM cells, as measured by enzyme immunoassay. sGCalpha and sGCbeta isoform expression were determined using Western blot analysis.
RESULTS: Activation of sGC is necessary for the NO-induced increases in outflow facility (0.3215 microL/min per mm Hg [baseline outflow facility]+/-0.0837 [SEM]). NO resulted in increased sGC activity that was abolished by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-1 (ODQ). Western blot analysis of total protein demonstrated an equivalent ratio of sGCalpha and sGCbeta subunit expression. In transformed cell fractions, however, the level of cytoplasmic sGCalpha subunit expression was decreased compared with low-passage human TM cells.
CONCLUSIONS: Activation of sGC is involved in the NO-induced increases in outflow facility. The expression of alpha and beta sGC subunits in an equivalent ratio would suggest a functional sGC heterodimer because DETA-NO increased cGMP levels in low-passage human and porcine TM cells. However, the inability of DETA-NO to cause increases in cGMP levels in transformed TM cells suggests that though the sGC heterodimer is necessary, it is not sufficient and may require other factors not present in transformed cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074804     DOI: 10.1167/iovs.08-2750

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  26 in total

1.  Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.

Authors:  Lauren K Wareham; Ana C Dordea; Grigorij Schleifer; Vincent Yao; Annabelle Batten; Fei Fei; Joseph Mertz; Meredith Gregory-Ksander; Louis R Pasquale; Emmanuel S Buys; Rebecca M Sappington
Journal:  Neurobiol Dis       Date:  2018-09-10       Impact factor: 5.996

2.  Role of nitric oxide in murine conventional outflow physiology.

Authors:  Jason Y H Chang; W Daniel Stamer; Jacques Bertrand; A Thomas Read; Catherine M Marando; C Ross Ethier; Darryl R Overby
Journal:  Am J Physiol Cell Physiol       Date:  2015-06-03       Impact factor: 4.249

3.  Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with hypertension, alcohol intake, and cigarette smoking.

Authors:  Jae Hee Kang; Janey L Wiggs; Bernard A Rosner; Jonathan Haines; Wael Abdrabou; Louis R Pasquale
Journal:  Arch Ophthalmol       Date:  2011-06

4.  Kappa opioid receptor localization and coupling to nitric oxide production in cells of the anterior chamber.

Authors:  Karen R Russell-Randall; Juanita Dortch-Carnes
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-13       Impact factor: 4.799

Review 5.  Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension.

Authors:  Paul L Kaufman
Journal:  Expert Opin Pharmacother       Date:  2017-02-20       Impact factor: 3.889

6.  Association of CAV1/CAV2 genomic variants with primary open-angle glaucoma overall and by gender and pattern of visual field loss.

Authors:  Stephanie J Loomis; Jae H Kang; Robert N Weinreb; Brian L Yaspan; Jessica N Cooke Bailey; Douglas Gaasterland; Terry Gaasterland; Richard K Lee; Paul R Lichter; Donald L Budenz; Yutao Liu; Tony Realini; David S Friedman; Catherine A McCarty; Sayoko E Moroi; Lana Olson; Joel S Schuman; Kuldev Singh; Douglas Vollrath; Gadi Wollstein; Donald J Zack; Murray Brilliant; Arthur J Sit; William G Christen; John Fingert; Peter Kraft; Kang Zhang; R Rand Allingham; Margaret A Pericak-Vance; Julia E Richards; Michael A Hauser; Jonathan L Haines; Louis R Pasquale; Janey L Wiggs
Journal:  Ophthalmology       Date:  2013-10-25       Impact factor: 12.079

7.  Nitric oxide regulation of Na, K-ATPase activity in ocular ciliary epithelium involves Src family kinase.

Authors:  Mohammad Shahidullah; Amritlal Mandal; Guojun Wei; Nicholas A Delamere
Journal:  J Cell Physiol       Date:  2014-03       Impact factor: 6.384

8.  Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility.

Authors:  W Michael Dismuke; Jin Liang; Darryl R Overby; W Daniel Stamer
Journal:  Exp Eye Res       Date:  2013-12-27       Impact factor: 3.467

9.  The ocular pulse decreases aqueous humor outflow resistance by stimulating nitric oxide production.

Authors:  Michael Madekurozwa; W Daniel Stamer; Ester Reina-Torres; Joseph M Sherwood; Darryl R Overby
Journal:  Am J Physiol Cell Physiol       Date:  2021-01-13       Impact factor: 4.249

Review 10.  The vital role for nitric oxide in intraocular pressure homeostasis.

Authors:  Ester Reina-Torres; Michael L De Ieso; Louis R Pasquale; Michael Madekurozwa; Joseph van Batenburg-Sherwood; Darryl R Overby; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2020-11-28       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.